2006
DOI: 10.1016/j.npep.2006.01.003
|View full text |Cite
|
Sign up to set email alerts
|

The role of the central thromboxane A2 in cardiovascular effects of a phospholipase A2 activator melittin administrated intracerebroventricularly in normotensive conscious rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
12
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 22 publications
1
12
0
Order By: Relevance
“…Furthermore, a recent report demonstrated that i.c.v. administration of melittin, a PLA 2 activator, affects the cardiovascular system and increases BP in both normal 11–13 and hypotensive settings 13 . In the present study, the pressor response induced by centrally injected AA is in agreement with the results of previous studies reporting that i.c.v.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Furthermore, a recent report demonstrated that i.c.v. administration of melittin, a PLA 2 activator, affects the cardiovascular system and increases BP in both normal 11–13 and hypotensive settings 13 . In the present study, the pressor response induced by centrally injected AA is in agreement with the results of previous studies reporting that i.c.v.…”
Section: Discussionsupporting
confidence: 93%
“…administration of melittin, a PLA 2 activator, affects the cardiovascular system and raises blood pressure under both normal 11–13 and hypotensive conditions 13 . Activation of central TXA 2 receptors contributes to these effects of melittin 11 and increases in plasma catecholamine, vasopressin and renin activity mediate the cardiovascular responses to melittin under both conditions 13 . Taken together, the results of these studies suggest that activation of PLA 2 by melittin may increase AA levels in target cells, leading to increased synthesis of PGs, including TXA 2 .…”
Section: Introductionmentioning
confidence: 99%
“…Melittin is a powerful PLA2 activator [22, 23] and releases arachidonic acid from plasma membrane [24, 25]. It is most likely that topical application of melittin caused the release of COX/LOX metabolites such as prostaglandins and HPETEs by activating the PLA2-COX/LOX pathway.…”
Section: Discussionmentioning
confidence: 99%
“…Its effects on the cardiovascular system [12] and insulin secretion [13] have also been demonstrated and attributed to the activation of phospholipase A 2 . However, MLT is extremely cytotoxic and potentially immunogenic [14] and thus not clinically used.…”
Section: Introductionmentioning
confidence: 99%
“…An amphipathic molecule with a hydrophobic N-terminal region (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20) and a hydrophilic C-terminus (21)(22)(23)(24)(25)(26), MLT has a random coil conformation in dilute aqueous solutions [2]. MLT has two regions of a-helix separated by a proline 'hinge' in aqueous solutions at high concentrations or in hydrophobic environments, such as alcohols or lipid bilayers [3].…”
Section: Introductionmentioning
confidence: 99%